Please login to the form below

Not currently logged in
Email:
Password:

Thomas Shenk leaves Merck board to focus on forthcoming antiviral company

Aims to commercialise research work carried out at Princeton University

Thomas Shenk - formerly of MerckThomas Shenk has retired from Merck & Co's board of directors after 11 years.

He has left to focus on a new business build on his work with Princeton University, where he has been Elkins Professor in the department of molecular biology since 1984 and served as chairman of the department from 1996 to 2004.

His forthcoming company will aim to commercialise discoveries in the field of antiviral therapy made at his Princeton laboratory.

Shenk's research includes work with fellow academic Ileana Cristea to research sirtuins – enzymes that can stem viral infections.

The broad antiviral activity of sirtuins indicates they can be used to treat a number of viral diseases.

A provisional patent application has been filed by Shenk and Cristea on known sirtuin agonists and several dual antagonists as broad spectrum antiviral therapeutics.

Shenk is also director of the Fox Chase Cancer Center – a Philadelphia-based hospital specialising in the treatment, research and prevention of cancer – and editor-in-chief for The Journal of Virology.

10th February 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...